Equity Profile

CRL

Charles River Laboratories International, Inc.

Health CareLife Sciences Tools & Services$8.7B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Charles River Laboratories International, Inc. (CRL) is a key player in the health care sector, providing essential services and tools for life sciences research....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in a competitive industry.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRL Q2-2026 Earnings Preview

Context

Company Snapshot

Charles River Laboratories International, Inc. (CRL) is a key player in the health care sector, providing essential services and tools for life sciences research. The company plays a vital role in the drug development process, helping pharmaceutical and biotechnology companies bring new therapies to market efficiently.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.31%

Avg Stock Reaction

+1.27%

Last Quarter Recap

In Q1-2026, Charles River Laboratories reported an EPS of $2.06, surpassing expectations by 5.21%. However, the stock experienced a slight decline of 0.03% the following day, indicating mixed investor sentiment despite the positive earnings surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about CRL's upcoming earnings, given its strong track record of beating EPS estimates. However, there is uncertainty regarding revenue figures and overall market conditions.

Bull Case

If CRL continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a decline in stock price, especially given the recent mixed reactions to earnings reports.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given CRL's history of beating EPS estimates, the market will closely watch this figure to gauge the company's profitability and growth trajectory.

How is revenue growth trending in the current market environment?

Understanding revenue trends is crucial for assessing the company's ability to maintain its competitive edge and respond to market demands.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CRL's ability to maintain strong EPS growth due to its focus on innovative services that cater to evolving market needs.

Supporting Evidence

CRL has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting that investors are anticipating significant news.

Key Risk

If CRL's EPS exceeds $2.20, it could challenge current market expectations and lead to a reassessment of growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether CRL can sustain its growth momentum amid market fluctuations.

Bull Confirmed If

A reported EPS of $2.20 or higher would confirm strong performance and support the bull case.

Bear Confirmed If

An EPS below $1.90 would raise concerns about the company's growth prospects and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.47%

Historical Avg

±8.5%

Pricing rich

The options market is pricing in a significant move of about 10.5% in either direction following the earnings report, indicating heightened uncertainty among investors.

Options are pricing ±10.0% while CRL has averaged ±8.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

60.1%

Calls (154K)P/C Ratio: 1.46Puts (22K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 30 (47%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 30 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.6%, with a raw directional average of +2.5% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CRL beats expectations, history suggests a potential stock increase of around 1.27%, confirming investor confidence in its growth.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a significant decline, with historical data indicating an average drop of around 0% following misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings or innovations in drug development.
2Insights into market demand trends and how CRL is positioning itself.
3Management's commentary on cost management and gross margin expectations.
4Details on client acquisition and retention rates.
5Any guidance on future revenue growth or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Charles River Laboratories International, Inc. (CRL) is a key player in the health care sector, providing essential services and tools for life sciences research....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in a competitive industry.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CRL Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.31%

Avg Stock Reaction

+1.27%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If CRL continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a decline in stock price, especially given the recent mixed reactions to earnings reports.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given CRL's history of beating EPS estimates, the market will closely watch this figure to gauge the company's profitability and growth trajectory.

How is revenue growth trending in the current market environment?

Understanding revenue trends is crucial for assessing the company's ability to maintain its competitive edge and respond to market demands.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate CRL's ability to maintain strong EPS growth due to its focus on innovative services that cater to evolving market needs.

Supporting Evidence

CRL has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting that investors are anticipating significant news.

Key Risk

If CRL's EPS exceeds $2.20, it could challenge current market expectations and lead to a reassessment of growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether CRL can sustain its growth momentum amid market fluctuations.

Bull Confirmed If

A reported EPS of $2.20 or higher would confirm strong performance and support the bull case.

Bear Confirmed If

An EPS below $1.90 would raise concerns about the company's growth prospects and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.47%

Historical Avg

±8.5%

Pricing rich

The options market is pricing in a significant move of about 10.5% in either direction following the earnings report, indicating heightened uncertainty among investors.

Options are pricing ±10.0% while CRL has averaged ±8.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

60.1%

Calls (154K)P/C Ratio: 1.46Puts (22K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 30 (47%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CRL beats expectations, history suggests a potential stock increase of around 1.27%, confirming investor confidence in its growth.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

A miss could lead to a significant decline, with historical data indicating an average drop of around 0% following misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings or innovations in drug development.
2Insights into market demand trends and how CRL is positioning itself.
3Management's commentary on cost management and gross margin expectations.
4Details on client acquisition and retention rates.
5Any guidance on future revenue growth or strategic initiatives.